Replies to post #106742 on OWC Pharmaceutical Research Corp (OWCP)

[kbaz]

Yes I believe so to and Sounds like the relationship between Bignitz and Hirsch is Long one of Serious Trust and Respect.

OWCP could use the NASDAQ Exposure, as well as the protection by FOMX from the Media pressure in order to focus on Gods work in the Promised Land.

FOMX is voting on 40million AS increase. Why do that when you are sitting on 31 million in cash and your quarterly Total Expenditures is only $13 million.

Something beautiful is about to happen for the longs, and those in the Market that could use the Medicine.

IMHO.

[stockfan100]

Connecting more dots between OWCP and FOMX?...They have a lot more in common that we know...AIMO

FOAMIX FMX103 phase 3 start in rosacea is scheduled for mid-2017 with a data readout sometime in 2018

https://seekingalpha.com/article/4059298-foamix-setback-yes-thesis-killer

FMX103 for Rosacea
Rosacea is a chronic skin disorder that is characterized by facial redness and inflammatory lesions, afflicting an estimated 14 million people in the U.S. alone. There are several drugs currently prescribed for treating rosacea. The most commonly used topical drugs are azelaic acid, and metronidazole. Oral antibiotics, such as doxycycline and minocycline are also routinely prescribed.

Rosacea lesions and inflammatory acne lesions are dermatologically similar in many ways. Based on our clinical data of FMX101 for moderate-to-severe acne, we intend to conduct initial clinical trials in the belief that FMX103 will be a safe and effective treatment for rosacea.

Phase II Clinical trial with FMX103 for rosacea is under way.

http://foamix.co.il/lead.asp?nodeID=551